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Abstract
Background: Shared genetic factors may contribute to the phenotypic clustering of different components of the
metabolic syndrome (MES). This study aims to identify genetic loci that contribute to individual or multiple factors
related to MES.
Results: We studied 478 normoglycemic subjects ascertained through 163 families participating in the Hong Kong
Family Diabetes Study. Factor analysis on 15 MES-related traits yielded 6 factors including adiposity factor (body
mass index, waist and hip circumferences), insulin factor (fasting insulin and insulin AUC during OGTT), glucose
factor (fasting glucose and glucose AUC during OGTT), TC-LDLC factor (total cholesterol and LDL-cholesterol),
blood pressure factor (systolic and diastolic blood pressure) and TG-HDLC factor (triglycerides and HDL-cholesterol).
Genome-wide linkage analyses were performed on these factors using variance component approach. Suggestive
evidence for linkage (LOD = 1.24 - 2.46) were observed for adiposity factor (chromosome 1 at 187 cM,
chromosome 9 at 34 cM and chromosome 17 at 10 cM), insulin factor (chromosome 2 at 128 cM, chromosome 5
at 21 cM and chromosome 12 at 7 cM), glucose factor (chromosome 7 at 155 cM), TC-LDLC factor (chromosome 7
at 151 cM and chromosome 13 at 15 cM) and TG-HDLC factor (chromosome 7 at 155 cM).
Conclusions: In summary, our findings suggest the presence of susceptibility loci that influence either single
(chromosomes 1, 2, 5, 9, 12, 13 and 17) or multiple factors (chromosome 7) for MES in Hong Kong Chinese without
diabetes.
Background
Metabolic syndrome (MES) represents a clustering of
multiple metabolic abnormalities, including insulin resis-
tance, glucose intolerance, hyperinsulinemia, dyslipide-
mia, hypertension, and obesity [1,2]. These metabolic
factors interact to substantially increase the risk of car-
diovascular diseases, chronic kidney disease, and type 2
diabetes (T2D) [3-5]. Similar to figures reported in the
US, [6], the prevalence of MES ranges from 10% to 30%
in Asian populations [7]. In Hong Kong, where 95% or
more of the residents are Han Chinese, the prevalence
of MES was 17% in 2000 [8]. After 6 years of follow up,
subjects with MES had 4-5 fold increased risk of new
onset of diabetes [9] and 2-3 fold increased risk of heart
disease and all-cause mortality [10].
Principal component factor analysis (PCFA) is a multi-
variate statistical technique used to extract a set of
latent or underlying independent factors from a large
number of inter-correlated variables. Edwards et al. [11]
firstly used factor analysis to understand the underlying
relationships among metabolic risk variables. In the past
decade, we [12,13] and others have reported the compo-
sition of multiple factors and their overlapping nature in
subjects with MES [14-18].
In a working population of Hong Kong Chinese, we
used structural equation modelling and identified age,
family history and obesity as the major explanatory vari-
ables for all components of MES including insulin resis-
tance [13]. In the Hong Kong Family Diabetes Study
(HKFDS), we further demonstrated that all metabolic
traits of MES including adiposity, blood pressure, lipids,
insulin resistance and beta-cell function were highly
heritable (heritability = 0.45 - 0.63) [19]. Subsequent
genome-wide linkage analyses of this family-based
cohort revealed linkage at multiple chromosomal
regions for diabetes, MES and/or related quantitative
traits [20,21].
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gested that different factors of MES may be regulated by
shared genetic factors which may partly explain the
clustering of MES factors within an individual [22,23].
In this study, we applied PCFA to identify six indepen-
dent factors of MES (adiposity, insulin, glucose, TC-
LDLC, blood pressure and TG-HDLC factors). Then we
tested for the hypothesis if shared or independent
genetic factors contribute to these MES factors by per-
forming genome-wide linkage analysis in 478 normogly-
cemic subjects from 163 families ascertained from the
HKFDS.
Results
The clinical characteristics of 478 normoglycemic family
members in 163 families are summarized in Table 1.
Table 2 shows the pairwise Pearson product moment
correlation coefficients of the 15 MES-related quantita-
tive traits. The adiposity traits were highly correlated
with each other (r > 0.76). In addition, body mass index
(BMI) and waist circumference (WC) showed moderate
correlations with all other traits (r = 0.24 to 0.44). On
the other hand, HDL-cholesterol (HDLC) showed mod-
erate inverse correlations with other traits (r = -0.13 to
-0.39), except for total cholesterol (TC).
In the factor analysis of these 15 traits, six factors
were extracted and cumulatively explained 82% of the
total variance (Table 3). The six extracted factors are
consistent with the inter-relationship among closely
related traits (Table 2) and are interpreted as follows:
Factor 1 refers to “adiposity factor”, with high positive
loadings of BMI, WC and hip circumference (HC); fac-
tor 2 refers to “insulin factor” with strong positive corre-
lations with plasma insulin (PI) areas under the curve
(AUC) for 0 - 30 min and PI AUC for 0 - 120 min and
moderate positive correlation with fasting PI; factor 3
refers to “glucose factor” with high positive correlations
among fasting plasma glucose (PG), PG AUC for 0 - 30
min and PG AUC for 0 - 120 min; factor 4 refers to
“TC-LDLC factor”, dominated by a high positive corre-
lation between TC and LDL-cholesterol (LDLC); factor
5 refers to “BP factor”, with large positive loadings for
systolic and diastolic blood pressure (SBP and DBP); fac-
tor 6 refers to “TG-HDLC factor”,w i t hs t r o n gb u t
inverse relationship between triglycerides (TG) and
HDLC. All six factors showed moderate to high herit-
abilities, ranging from 29 to 67% (Table 3).
In the variance component multipoint linkage ana-
lyses, we observed suggestive evidence of linkages
(empirical p-value < 0.01) on chromosomes 1, 9 and 17
for adiposity factor (LOD = 1.92 - 2.46), chromosomes
2, 5 and 12 for insulin factor (LOD = 1.61 - 2.23), chro-
mosome 7 for glucose factor (LOD = 2.16) and TG-
HDLC factor (LOD = 1.96), as well as chromosomes 7
and 13 for TC-LDLC factor (LOD = 1.24 - 1.43) (Table
4 and Figure 1). Of note, the chromosome 7 region at
155 cM demonstrated a clustering of linkage signals for
glucose, TC-LDLC and TG-HDLC factors. When the
linkage results from PCFA were compared to that of
their respective individual components (see Additional
file 1), we observed consistent linkages for individual
components for adiposity factor on chromosomes 1 and
9 and for glucose factor on chromosome 7, with the
linkage signals from PCFA stronger than the individual
components (Figure 2). On the other hand, the linkage
signals for PCFA factors in other regions were modest
compared to the varied linkage signals strength for indi-
vidual components (see Additional file 1).
Discussion
This genome scan analysis was performed in normogly-
cemic subjects in the HKFDS. The original study con-
sists of 913 first degree relatives recruited from 179
families with predominantly young-onset diabetes. In
this cohort, 53% of the probands and 25% of the siblings
had MES. All metabolic traits of MES demonstrated
high heritability estimates ranging from 0.45 to 0.63
[19]. In a linkage analysis based on 64 families with 126
affected sib-pairs segregating the diabetes trait, we iden-
tified suggestive linkage to chromosomes 1, 4, 6 and 12
[20]. In a follow up analysis using the entire family-
based cohort, we reported suggestive linkage of MES
traits to chromosomes 1, 2 and 16 [21].
Table 1 Clinical characteristics of normoglycemic first
degree relatives recruited from 163 families of probands
with diabetes.
Characteristics Value
N 478
Male/female 199/279
Age (years ) 37 ± 13
Body mass index (kg/m
2) 23.8 ± 4.1
Waist circumference (cm) 78 ± 10
Hip circumference (cm) 96 ± 8
Fasting Insulin (pmol/l) 46 (43 - 48)
Insulin AUC 0 - 30 minutes (pmol/l) 6000 (5668 - 6352)
Insulin AUC 0 - 120 minutes (pmol/l) 38897 (36954 - 40964)
Fasting plasma glucose (mmol/l) 4.9 ± 0.5
Plasma glucose AUC 0 - 30 min (mmol/l) 202.1 ± 29.5
Plasma glucose AUC 0 - 120 min (mmol/l) 887.4 ± 199.4
Systolic blood pressure (mmHg) 120 ± 17
Diastolic blood pressure (mmHg) 73 ± 12
Total cholesterol (mmol/l) 5.0 ± 1.0
LDL cholesterol (mmol/l) 3.0 ± 0.9
Triglyceride (mmol/l) 1.01 (0.96 - 1.06)
HDL cholesterol (mmol/l) 1.4 ± 0.4
Data are shown as mean ± SD or geometric mean (95% CI). AUC, Area under
curve
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Page 2 of 9To delineate whether the linkage signals observed in
our previous linkage studies affect single or multiple
metabolic factors, we genotyped additional microsatellite
markers within these previously linked regions. Only
subjects with normoglycemia were analyzed in the pre-
sent study in order to avoid possible modifying effect of
diabetes on the metabolic traits. Using PCFA, we identi-
fied six discrete factors loaded with closely related
variables, namely adiposity, insulin, glucose, TC-HDLC,
TC-LDLC and BP. Principal component factor analysis
(PCFA) aimed to reduce a set of observable variables to
a small number of latent factors that account for the
correlations among observed variables. This analysis
strategy compensates the problem associated with multi-
ple comparisons and increases the power significantly
[24]. For example, only one test of linkage analysis was
Table 2 Pearson product moment correlation coefficients of the 15 metabolic syndrome-related traits in
normoglycemic family members.
Phenotype 123456789 1 0 1 1 1 2 1 3 1 4 1 5
1. BMI –
2. WC 0.854 –
3. HC 0.825 0.776 –
4. Fasting PI 0.404 0.319 0.307 –
5. PI AUC 0 - 30 min 0.291 0.275 0.281 0.475 –
6. PI AUC 0 - 120 min 0.364 0.348 0.295 0.530 0.717 –
7. Fasting PI 0.353 0.419 0.253 0.174 -0.068 0.095 –
8. PG AUC 0 - 30 min 0.266 0.347 0.143 0.143 0.184 0.241 0.617 –
9. PG AUC 0 - 120 min 0.360 0.400 0.192 0.180 -0.014 0.327 0.576 0.718 –
10. SBP 0.367 0.438 0.278 0.096 0.027 0.074 0.329 0.309 0.354 –
11. DBP 0.386 0.419 0.246 0.190 0.099 0.130 0.234 0.241 0.288 0.741 –
12. TC 0.242 0.306 0.141 0.023 -0.007 0.060 0.264 0.261 0.239 0.165 0.112 –
13. LDL 0.276 0.354 0.200 0.015 -0.003 0.069 0.290 0.264 0.236 0.154 0.109 0.930 –
14. TG 0.303 0.361 0.203 0.268 0.256 0.314 0.275 0.302 0.299 0.169 0.170 0.287 0.199 –
15. HDL -0.298 -0.391 -0.259 -0.169 -0.153 -0.250 -0.240 -0.173 -0.198 -0.139 -0.157 0.105 -0.131 -0.387 –
Table 3 Factor loadings and variance explained by the factors after varimax rotation in the PCFA model.
Phenotype/Interpretation Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6
Adiposity Insulin Glucose TC-LDL Blood Pressure TG-HDL
Body mass index (kg/m
2)
a 0.87 0.24 0.15 0.10 0.16 -0.15
Waist circumference (cm)
a 0.87 0.22 0.17 0.09 0.16 -0.19
Hip circumference (cm)
a 0.93 0.13 0.06 0.06 0.10 -0.05
Fasting Insulin (pmol/l)
a 0.23 0.68 0.09 0.03 0.17 -0.12
Insulin AUC 0 - 30 minutes (pmol/l)
b 0.13 0.90 -0.03 -0.01 0.00 -0.02
Insulin AUC 0 - 120 minutes (pmol/l)
b 0.16 0.86 0.21 0.02 0.03 -0.15
Fasting plasma glucose (mmol/l)
a 0.23 -0.09 0.76 0.08 0.06 -0.13
Plasma glucose AUC 0 - 30 min (mmol/l)
a 0.00 0.21 0.87 0.05 0.05 0.01
Plasms glucose AUC 0 - 120 min (mmol/l)
a 0.10 0.12 0.84 0.03 0.12 -0.13
Systolic blood pressure (mmHg)
a 0.19 0.00 0.15 -0.05 0.88 -0.03
Diastolic blood pressure (mmHg)
a 0.12 0.15 0.04 -0.02 0.91 -0.06
Total cholesterol (mmol/l)
a 0.05 0.03 0.06 0.99 -0.01 0.04
LDL cholesterol (mmol/l)
b 0.13 0.00 0.07 0.94 -0.06 -0.08
Triglyceride (mmol/l)
a 0.11 0.20 0.14 0.26 0.10 -0.79
HDL cholesterol (mmol/l)
b -0.18 -0.06 -0.09 0.16 0.00 0.87
Eigenvalue 4.72 1.99 1.73 1.57 1.27 1.09
Total variance (%) 31.45 13.29 11.55 10.44 8.46 7.28
Cumulative variance (%) 31.45 44.74 56.29 66.73 75.18 82.46
Heritabilities 61.69 55.62 28.58 67.03 64.15 64.00
a and
b indicates natural logarithm and square root transformation. Factor loadings > 0.4 are highlighted in boldface.
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Page 3 of 9applied on the adiposity factor in our study instead of
three linkage tests on the corresponding individual
quantitative traits including BMI, WC, and HIP.
Many of our linkage signals were linked to chromosomal
regions observed by other genome scans for hypertension
[25,26], fasting insulin [27,28], dyslipidemia [29], visceral
fat area [30] and/or low metabolic rates [31]. Interestingly,
several of these regions were also linked to obstructive
sleep apnoea [32] which is closely associated with obesity.
Additional file 2, table S2 summarized the linkage findings
in the present and other previous studies.
Despite excluding subjects with diabetes, we found
significant linkage of adiposity factor to chromosome 1q
at the 187 cM region. The linkage of chromosome 1q
21-25 region to type 2 diabetes has been replicated in at
least 8 independent populations suggesting that this
region is likely to harbor major gene(s) for diabetes and/
or MES [33]. The overlapping nature of this region
linked to diabetes, MES and adiposity traits in our
families suggests that genetic variants in this region may
interact with other factors to give rise to diabetes. In
addition, we found regions linked to adiposity on
Table 4 Regions showing nominal evidence of multipoint linkage (empirical p-value < 0.01) to the factors.
Factors Interpretation Chr Position (cM)
a Flanking markers LOD Empirical P-value
1 Adiposity 1 187 DIS466 - D1S202 2.22 0.0022
9 34 GATA187D09 - D9S925 1.92 0.0038
17 10 D17S1308 - D17S1298 2.46 0.0013
2 Insulin 2 128 D2S2972 - D2S1328 2.23 0.0018
5 21 D5S2505 - D5S1486 1.61 0.0070
12 7 D12S372 1.92 0.0037
3 Glucose 7 155 D7S1804 - GATA104 2.16 0.0003
4 TC-LDLC 7 151 D7S1804 - GATA104 1.24 0.0090
13 15 D13S787 - ATA5A09 1.43 0.0064
6 TG-HDLC 7 155 D7S1804 - GATA104 1.96 0.0020
a Marker positions are indicated as cM from pter in the deCODE Map.
Figure 1 Multipoint linkage analyses results of the six factors. The horizontal axis is cM from p-terminus.
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Page 4 of 9chromosomes 9 (34 cM) and 17 (10 cM). These regions
were close to the linkage signals reported in other gen-
ome scans of MES or related traits. In the GIFT Study,
a significant evidence for a region on chromosome 17
(29 - 58 cM) linked to T2D was reported [34]. This
region contains a large number of genes which may
influence various transcription and signaling pathways
in energy metabolism. These include glucagon-like pep-
tide 2 receptor (GLP2R), mitogen-activated protein
kinases (MAPK) MAP2K4 and MAP2K3; transcription
factors, (STAT)5A and STAT5B, neuropeptide pancreatic
polypeptide 2 (PPY2); complement C1q receptor protein
(C1QBP); lipoxygenase (LO) gene family, ALOX12 and
ALOX15 [27]. The other regions on chromosome 9
linked to adiposity factor in our cohort were also signifi-
cant in other genome scans for hypertension [26], famil-
ial dyslipidemia [29], visceral fat area [30] and HDLC
[30,35] in other populations.
In this analysis, the insulin factor was linked to the
128 cM of chromosome 2. Interestingly, an adjacent
region at 94-118 cM has been reported in several gen-
ome scans for hypertension in both Caucasian and
Figure 2 Comparisons of multipoint linkage analyses results for metabolic factors and its individual components. a) Adiposity factor vs
BMI, WC and HC on chromosome 1. b) Adiposity factor vs BMI, WC and HIP on chromosome 9. c) Glucose factor vs fasting plasma glucose (PG),
PG AUC 0-30 minutes and PG AUC 0-120 minutes on chromosome 7. The horizontal axis is cM from p-terminus.
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Page 5 of 9African populations [26,36]. This region harbors a num-
ber of genes which regulate blood pressure and vascular
reactivity such as the a2b adrenergic receptor gene, a
key component of the sympathetic nervous system,
SCN7A of the sodium channel and NOSTRIN which is
related to the NO pathways [36].
The other region of interest is chromosome 5 at 21
cM which was also linked to the insulin factor. In a
recent 2-dimensional genome scan for hypertension,
novel epistatic loci was identified notably on chromo-
some 5q13.14 which interact with chromosomes 9, 11,
15, 16 and 19 [37]. In the Hypertension Genetic Epide-
miology Network (HyperGEN) of the Family Blood Pres-
sure Program, a genome scan also identified a linkage
signal on chromosome 5 at 20 cM with a LOD score of
2.36 in European Americans. Both diabetes and hyper-
tension are heterogeneous disorders with multiple and
interacting aetiologies, including activation of stress hor-
monal systems, hyperinsulinemia, abnormal vascular
smooth muscle cellular growth and sodium and water
retention [38]. To this end, subjects with genetic predis-
position to hyperinsulinemia are prone to develop
hypertension, which may be accelerated by obesity-asso-
ciated insulin resistance. In support of this notion, the
candidate genes located in this region include b2-adre-
nergic receptor (ADRB2), natriuretic peptide receptor C
(NRP3) and islet-1 (ISL1). ADRB2 is involved in vasodi-
lation [39] while NRP3 inhibits adenyl cyclase [40], both
of which are implicated in blood pressure control. The
other candidate, ISL1, is a transcription factor that regu-
lates insulin gene expression in the pancreatic islets [41].
The 155 cM region of chromosome 7 was linked to
both glucose and lipid factors (TC-LDLC and TG-
HDLC). Of note, nearby regions at 109-123 cM and 134
cM have been linked to low HDLC and visceral fat in
other populations [30]. Ectopic especially visceral fat
plays pivotal role in insulin resistance mainly through
increased production of free fatty acids and cytokines.
Insulin resistance in turn can lead to non-suppression of
lipolysis and increased hepatic glucose production lead-
ing to hyperglycemia and dyslipidemia as components of
the MES [42].
In this analysis, we identified six factors during factor
analysis whereas other studies reported three to four
factors only [22,23,43]. In the latter case, the insulin
variables are commonly loaded on the same factor as
adiposity variables. Our seemingly discrepant results
might be due to population differences. For example,
the study populations reported by Tang et al. [23] and
Arya et al. [22] were substantially more obese (mean
BMI = 27.6-28 and 29.1 kg/m
2, respectively) than our
cohort (BMI = 23.8 kg/m
2). Since hyperinsulinemia and
insulin resistance are mainly found in obese subjects,
correlation between obesity and insulin resistance is
l i k e l yt ob em o r er o b u s ti na no b e s et h a nar e l a t i v e l y
lean population, such as Chinese.
Moreover, the nature and number of metabolic vari-
ables used to generate composite factors of the MES
vary substantially across studies. While Bossé [43] and
Arya [22] included eight MES-related variables, we
included fifteen variables in our analysis. In the former
studies [43,22], only TG and HDLC were used as the
lipid variables and no oral glucose tolerance test
(OGTT) data were presented. By contrast, we included
four variables (TC, TG, LDLC and HDLC) to quantify
dyslipidemia and included AUC for PG and PI during
OGTT at 0-30 min and 0-120 min for insulin secretion.
This comprehensive phenotypic dataset allows us to
identify two blood lipid factors and segregate insulin
resistance factor into its glucose and insulin compo-
nents, which can have different biological determinants.
There are several limitations to this study. Firstly, we
examined normoglycemic subjects only in order to
exclude the impact of diabetes and medications on the
measures of metabolic traits. Although such exclusion
m a yr e d u c es a m p l es i z ea n ds t u d yp o w e r ,o u rr e s u l t si n
this subgroup analysis accord with our previously
reported linkages to type 2 diabetes and individual MES-
related traits in 1q21-25 regions [20,21], along with
reports from other populations [33]. Secondly, in the era
of genome-wide association studies where reproducible
common genetic variants are successfully identified in
complex diseases, there are fewer successful examples for
discovering complex disease genes using the linkage
approach alone [44,45]. However, linkage results are
complementary and can be used to prioritize the linkage
regions for investigation and follow up in genome-wide
association and resequencing studies. This is exemplified
by the discovery of TCF7L2 gene with type 2 diabetes
[44,46]. Indeed, genome-wide linkage approach remains
essential until high throughput technology that allows
association analysis of both rare and common variants at
a affordable cost becomes available [47].
Conclusions
In conclusion, in a family-based cohort of normoglyce-
mic subjects ascertained through probands with predo-
minantly young onset diabetes, we found suggestive
linkages to adiposity, insulin, glucose and lipid factors
o nc h r o m o s o m e s1 ,2 ,5 ,7 ,9 ,1 2 ,1 3a n d1 7 .S o m eo f
these regions overlap or in close proximity to other gen-
ome scans of MES traits. With increasing understanding
of the pathogenesis of MES and related traits, explora-
tion of these regions and their interactions, including
epigenetics, will provide important insights into the nat-
ure of these interacting pathways and their relationships
with clinical presentations, thereby bringing personalized
diagnosis and therapy closer to reality.
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Subjects
The study design, ascertainment, inclusion criteria and
phenotyping of the HKFDS have been described else-
where [20]. Briefly, 478 normoglycemic individuals (42%
men) were selected from 163 families consisting of sib-
lings, parents, spouses, and offspring (>16 years) ascer-
tained through a proband with T2D. Patients with
clinical or autoimmune type 1 diabetes and families
with known maturity-onset diabetes of the young or
mitochondrial DNA nucleotide 3243 A > G mutations
were excluded. All first degree relatives underwent
extended phenotyping including 75 gram OGTT and
had complete phenotypic data for 15 MES traits. The
average family size was 3 (2 - 4) (median (interquartile
range)) members. Written informed consent was
obtained from all participating subjects. This study was
approved by the Clinical Research Ethics Committee of
the Chinese University of Hong Kong.
Clinical studies
Using a standardized protocol, all family members were
examined after at least 8 hours of overnight fast. They
underwent full clinical examination and completed a
questionnaire on personal, family, medical and lifestyle
histories. Anthropometric parameters including body
weight and height, WC and HC, SBP and DBP were
measured. Fasting blood samples were collected for
measurement of PG, PI, lipid profile (TC, TG, HDLC
and LDLC) and DNA extraction. AUC for PG and PI at
OGTT 0-30 min, 0-120 min were calculated using the
trapezoid rule.
Genotyping
Detailed information on PCR conditions, genotyping
procedure and quality control have been described [20].
Briefly, we made use of the Human Screening Set, ver-
sion 10 for the previous genome scans. A total of 355
microsatellite markers (Research Genetics, Huntsville,
AL) were genotyped across all 22 autosomes. The aver-
age spacing between markers was 10 cM, and average
heterozygosity was 71%. In this analysis, 70 additional
microsatellite markers were genotyped at chromosomes
1, 2, 4, 5, 6, 10, 12 and 16 to delineate whether the link-
age signals observed in our previous linkage studies for
diabetes, MES and its components [20,21] affect single
or multiple metabolic factors. Genetic relationships
among family members were checked by programs
RELPAIR [48] and PREST (Pedigree Relationship statis-
tical Test) [49], and corrected. Mendelian errors and
potential genotyping errors were checked by PED-
CHECK (version 1.1) [50] and MERLIN (version 1.01)
[51], respectively, and removed.
Statistical analysis
Data were transformed using natural logarithm (BMI,
WC, HIP, SBP, DBP, TC, TG, fasting PG, fasting PI, PG
AUC for 0 - 30 min and PG AUC for 0 - 120 min), or
square root (PI AUC for 0 - 30 minutes, PI AUC for 0 -
120 minutes, HDLC and LDLC) due to skewed distribu-
tions. Outliers (<0.3%) with values greater than or equal
to 4 standard deviations from the mean were removed.
Data were then standardized to zero mean and unit var-
iance by multiple linear regression models with age and
sex as covariates.
In the factor analysis model, the amount of variance
contributed by each factor was evaluated by eigenvalues,
which represent the sum of the squared factor loadings.
In the present study, factors with eigenvalues ≥1.0 were
extracted. We then applied varimax rotation method to
achieve a simple structure which showed improved
interpretability of factors that were consistent with the
underlying biological processes. Traits with factor load-
ings ≥0.40 in absolute value were used to interpret and
characterize the factor structures. Finally, a factor score,
which was the estimated values of underlying factor,
was calculated for each individual based on the factor
loadings and the values of observed phenotypes [23].
The factor analysis (using the PROC FACTOR proce-
dure) and other statistical analyses were performed in
SAS v.9.1 (SAS Institute, Cary, NC, USA) unless speci-
fied otherwise.
Multipoint variance components linkage analyses
implemented in SOLAR v.2.0 [52] were conducted on
the factor scores obtained from PCFA to identify linkage
for each factor. Estimated heritability for each factor was
also reported which estimated the proportion of total
variance attributed by the additive genetic variance. To
estimate our evidences of linkages, empirical p-values
were obtained through the simulation of 10,000 replica-
tions of a fully informative marker under the null
hypothesis of no linkage between marker and phenotype
using SOLAR. A LOD score ≥3.0 was considered as sig-
nificant evidence of linkage.
Additional file 1: Contains supplementary table 1 - Comparisons of
multipoint linkage analyses results for other metabolic factors and its
individual components.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-11-
14-S1.DOC]
Additional file 2: Contains supplementary table 2 - Supplementary
Table 2: Summary of linkage findings in the present and other previous
studies.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-11-
14-S2.DOC]
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